- Report
- June 2024
- 200 Pages
Global
From €7508EUR$7,950USD£6,386GBP
- Report
- October 2024
- 250 Pages
Global
From €4674EUR$4,949USD£3,975GBP
- Report
- September 2024
- 250 Pages
Global
From €4674EUR$4,949USD£3,975GBP
- Drug Pipelines
- August 2024
- 150 Pages
Global
From €2634EUR$2,789USD£2,240GBP
- Report
- April 2024
- 140 Pages
Global
From €4674EUR$4,949USD£3,975GBP
- Report
- April 2024
- 160 Pages
Global
From €4693EUR$4,969USD£3,991GBP
- Report
- May 2024
- 200 Pages
Global
From €3919EUR$4,150USD£3,334GBP
- Report
- May 2024
- 200 Pages
Global
From €3919EUR$4,150USD£3,334GBP
- Report
- July 2024
- 100 Pages
Global
From €3541EUR$3,750USD£3,012GBP
- Report
- July 2024
- 100 Pages
Global
From €3541EUR$3,750USD£3,012GBP
- Report
- July 2024
- 100 Pages
Global
From €3541EUR$3,750USD£3,012GBP
- Report
- January 2025
- 193 Pages
Global
From €2361EUR$2,500USD£2,008GBP
- Report
- October 2024
- 140 Pages
Global
From €2361EUR$2,500USD£2,008GBP
- Report
- August 2024
- 168 Pages
Global
From €2361EUR$2,500USD£2,008GBP
- Report
- July 2024
- 174 Pages
Global
From €2361EUR$2,500USD£2,008GBP
- Report
- July 2024
- 145 Pages
Global
From €2361EUR$2,500USD£2,008GBP
- Report
- July 2024
- 196 Pages
Global
From €4486EUR$4,750USD£3,815GBP
- Report
- September 2024
- 150 Pages
Global
From €4580EUR$4,850USD£3,896GBP
- Report
- March 2025
- 182 Pages
Global
From €4250EUR$4,500USD£3,615GBP
- Report
- February 2025
- 185 Pages
Global
From €4250EUR$4,500USD£3,615GBP

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more